Tunable chitosan-alginate capsules for a controlled release of crystallisation inhibitors in mortars

Plasters and renders used in historic monuments are vulnerable to degradation caused by salt weathering. Crystallisation inhibitors (molecules/ions that alter salt crystallisation) mixed into mortars have shown promising results in mitigating salt damage by inhibiting salt crystallisation, promoting...

Full description

Bibliographic Details
Main Authors: Kamat Ameya, Palin Damian, Lubelli Barbara, Schlangen Erik
Format: Article
Language:English
Published: EDP Sciences 2023-01-01
Series:MATEC Web of Conferences
Online Access:https://www.matec-conferences.org/articles/matecconf/pdf/2023/05/matecconf_smartincs2023_02011.pdf
_version_ 1797835216958521344
author Kamat Ameya
Palin Damian
Lubelli Barbara
Schlangen Erik
author_facet Kamat Ameya
Palin Damian
Lubelli Barbara
Schlangen Erik
author_sort Kamat Ameya
collection DOAJ
description Plasters and renders used in historic monuments are vulnerable to degradation caused by salt weathering. Crystallisation inhibitors (molecules/ions that alter salt crystallisation) mixed into mortars have shown promising results in mitigating salt damage by inhibiting salt crystallisation, promoting salt transport to the evaporating surface, and modifying crystal habit. However, past research suggests that inhibitors easily leach out from mortars, meaning their long-term positive effect is lost. Encapsulation of an inhibitor within a mortar is a potential solution to minimise leaching. Herein, capsules composed of a polyelectrolyte complex of calcium alginate coated in chitosan are investigated for the controlled diffusive release of sodium ferrocyanide, a known NaCl crystallisation inhibitor. Capsules with varying chitosan-calcium alginate ratios are prepared using the extrusion dripping technique. The release of the inhibitor from capsules in solutions of various pH values ranging from 7–13 is investigated. Results show that increasing the capsule’s chitosan to calcium alginate ratio reduces the inhibitor release for all studied solution pH values compared to pure calcium-alginate capsules. Therefore, a controlled inhibitor release can be obtained by tuning the chitosan-alginate ratio. In future, additional tests will be performed to find suitable capsule compositions for optimising their performance when mixed in mortars.
first_indexed 2024-04-09T14:50:38Z
format Article
id doaj.art-18bed1a428e84d61a4fa70fd2b24feb3
institution Directory Open Access Journal
issn 2261-236X
language English
last_indexed 2024-04-09T14:50:38Z
publishDate 2023-01-01
publisher EDP Sciences
record_format Article
series MATEC Web of Conferences
spelling doaj.art-18bed1a428e84d61a4fa70fd2b24feb32023-05-02T09:34:12ZengEDP SciencesMATEC Web of Conferences2261-236X2023-01-013780201110.1051/matecconf/202337802011matecconf_smartincs2023_02011Tunable chitosan-alginate capsules for a controlled release of crystallisation inhibitors in mortarsKamat Ameya0Palin Damian1Lubelli Barbara2Schlangen Erik3Delft University of Technology, Heritage and TechnologyUniversity of Cambridge, Department of EngineeringDelft University of Technology, Heritage and TechnologyDelft University of Technology, Materials and EnvironmentPlasters and renders used in historic monuments are vulnerable to degradation caused by salt weathering. Crystallisation inhibitors (molecules/ions that alter salt crystallisation) mixed into mortars have shown promising results in mitigating salt damage by inhibiting salt crystallisation, promoting salt transport to the evaporating surface, and modifying crystal habit. However, past research suggests that inhibitors easily leach out from mortars, meaning their long-term positive effect is lost. Encapsulation of an inhibitor within a mortar is a potential solution to minimise leaching. Herein, capsules composed of a polyelectrolyte complex of calcium alginate coated in chitosan are investigated for the controlled diffusive release of sodium ferrocyanide, a known NaCl crystallisation inhibitor. Capsules with varying chitosan-calcium alginate ratios are prepared using the extrusion dripping technique. The release of the inhibitor from capsules in solutions of various pH values ranging from 7–13 is investigated. Results show that increasing the capsule’s chitosan to calcium alginate ratio reduces the inhibitor release for all studied solution pH values compared to pure calcium-alginate capsules. Therefore, a controlled inhibitor release can be obtained by tuning the chitosan-alginate ratio. In future, additional tests will be performed to find suitable capsule compositions for optimising their performance when mixed in mortars.https://www.matec-conferences.org/articles/matecconf/pdf/2023/05/matecconf_smartincs2023_02011.pdf
spellingShingle Kamat Ameya
Palin Damian
Lubelli Barbara
Schlangen Erik
Tunable chitosan-alginate capsules for a controlled release of crystallisation inhibitors in mortars
MATEC Web of Conferences
title Tunable chitosan-alginate capsules for a controlled release of crystallisation inhibitors in mortars
title_full Tunable chitosan-alginate capsules for a controlled release of crystallisation inhibitors in mortars
title_fullStr Tunable chitosan-alginate capsules for a controlled release of crystallisation inhibitors in mortars
title_full_unstemmed Tunable chitosan-alginate capsules for a controlled release of crystallisation inhibitors in mortars
title_short Tunable chitosan-alginate capsules for a controlled release of crystallisation inhibitors in mortars
title_sort tunable chitosan alginate capsules for a controlled release of crystallisation inhibitors in mortars
url https://www.matec-conferences.org/articles/matecconf/pdf/2023/05/matecconf_smartincs2023_02011.pdf
work_keys_str_mv AT kamatameya tunablechitosanalginatecapsulesforacontrolledreleaseofcrystallisationinhibitorsinmortars
AT palindamian tunablechitosanalginatecapsulesforacontrolledreleaseofcrystallisationinhibitorsinmortars
AT lubellibarbara tunablechitosanalginatecapsulesforacontrolledreleaseofcrystallisationinhibitorsinmortars
AT schlangenerik tunablechitosanalginatecapsulesforacontrolledreleaseofcrystallisationinhibitorsinmortars